We are live on
!
Find out more
DF
DecisionPoint Financial Portfolio holdings
AUM
$464M
1-Year Est. Return
14.01%
This Fund
S&P 500
This Quarter
Est. Return
+6.7%
1 Year Est. Return
+14.01%
3 Year Est. Return
+34.49%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$392M
AUM Growth
+$46.9M
(+14%)
Cap. Flow
+$22.9M
Cap. Flow
% of AUM
5.85%
Top 10 Holdings %
Top 10 Hldgs %
84.43%
Holding
695
New
441
Increased
82
Reduced
44
Closed
52
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dimensional US Core Equity 1 ETF
DCOR
|
+$5.69M |
| 2 |
Dimensional US Core Equity 2 ETF
DFAC
|
+$5.61M |
| 3 |
DFAI
Dimensional International Core Equity Market ETF
DFAI
|
+$2.36M |
| 4 |
Dimensional US Small Cap ETF
DFAS
|
+$1.52M |
| 5 |
Vanguard Small-Cap ETF
VB
|
+$1.46M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Home BancShares
HOMB
|
+$1.71M |
| 2 |
Apple
AAPL
|
+$621K |
| 3 |
Schwab 5-10 Year Corporate Bond ETF
SCHI
|
+$395K |
| 4 |
Amazon
AMZN
|
+$208K |
| 5 |
Schwab US Mid-Cap ETF
SCHM
|
+$159K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 5.31% |
| 2 | Technology | 2.04% |
| 3 | Consumer Discretionary | 0.67% |
| 4 | Industrials | 0.37% |
| 5 | Communication Services | 0.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
551
Otis Worldwide
OTIS
$27.9B
| $302 | ﹤0.01% |
3
-107
| -97% | -$10.3K |
|
552
Banc of California
BANC
$2.93B
| $301 | ﹤0.01% |
+21
| New | +$286 |
|
553
Onto Innovation
ONTO
$10.9B
| $301 | ﹤0.01% |
+3
| New | +$320 |
|
554
Carrier Global
CARR
$50.6B
| $298 | ﹤0.01% |
4
-216
| -98% | -$14.7K |
|
|
FITB
555
Fifth Third Bancorp
FITB
$51.7B
| $298 | ﹤0.01% |
+7
| New | +$263 |
|
556
Origin Bancorp
OBK
$1.69B
| $297 | ﹤0.01% |
+8
| New | +$265 |
|
557
PG&E
PCG
$39.2B
| $297 | ﹤0.01% |
+21
| New | +$342 |
|
558
Omnicom Group
OMC
$23.4B
| $296 | ﹤0.01% |
+4
| New | +$295 |
|
559
Generac Holdings
GNRC
$11.4B
| $294 | ﹤0.01% |
+2
| New | +$244 |
|
560
United Therapeutics
UTHR
$26B
| $291 | ﹤0.01% |
+1
| New | +$299 |
|
561
UroGen Pharma
URGN
$1.98B
| $287 | ﹤0.01% |
+22
| New | +$211 |
|
562
Saia
SAIA
$10.5B
| $286 | ﹤0.01% |
+1
| New | +$285 |
|
563
BioLife Solutions
BLFS
$1.54B
| $282 | ﹤0.01% |
+13
| New | +$293 |
|
564
Phinia Inc
PHIN
$2.98B
| $282 | ﹤0.01% |
+6
| New | +$253 |
|
565
FormFactor
FORM
$6.59B
| $280 | ﹤0.01% |
+8
| New | +$243 |
|
566
Primerica
PRI
$10.1B
| $279 | ﹤0.01% |
+1
| New | +$265 |
|
567
Tanger
SKT
$4.82B
| $279 | ﹤0.01% |
+9
| New | +$276 |
|
|
XYZ
568
Block Inc
XYZ
$49.2B
| $274 | ﹤0.01% |
+4
| New | +$233 |
|
569
Dynatrace
DT
$12.9B
| $273 | ﹤0.01% |
+5
| New | +$250 |
|
570
CarGurus
CARG
$3.35B
| $270 | ﹤0.01% |
+8
| New | +$241 |
|
571
Affirm
AFRM
$23.9B
| $269 | ﹤0.01% |
+4
| New | +$207 |
|
572
Synaptics
SYNA
$4.14B
| $266 | ﹤0.01% |
+4
| New | +$235 |
|
573
Vulcan Materials
VMC
$37.1B
| $265 | ﹤0.01% |
+1
| New | +$257 |
|
|
ALE
574
DELISTED
Allete
ALE
| $259 | ﹤0.01% |
+4
| New | +$260 |
|
575
XPO
XPO
$23.7B
| $259 | ﹤0.01% |
+2
| New | +$224 |
|
Similar funds
CAG
FNBTCON
RAA
CWWM
HSA
CPIM
ACGA
SHWM
DecisionPoint Financial's Q2 2025 Portfolio in Review
As of Q2 2025, DecisionPoint Financial held 695 positions worth $392M, up 14% from $345M the previous quarter. Its ten largest holdings account for 84% of the portfolio.
DecisionPoint Financial deployed $22.9M of net new capital in Q2 2025, opening 441 new positions and adding to 82 existing holdings. Its largest new stake was Vanguard Total International Stock ETF: 11,621 shares worth $803K.
By sector, the portfolio is most concentrated in Financials at 5.3% of assets, down from 6.3% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Home BancShares, an estimated $1.71M trimmed.
- DecisionPoint Financial's largest Q2 2025 buy was Vanguard Total International Stock ETF: 11,621 shares worth $803K.
- DecisionPoint Financial added most to Dimensional US Core Equity 1 ETF in Q2 2025, an estimated $5.69M increase.
- DecisionPoint Financial's biggest Q2 2025 reduction was Home BancShares, cutting an estimated $1.71M.
- DecisionPoint Financial fully exited CRISPR Therapeutics in Q2 2025, selling an estimated $93.6K.
- DecisionPoint Financial's ten largest holdings make up 84% of its $392M portfolio in Q2 2025.
- DecisionPoint Financial opened 441 new positions and closed 52 in Q2 2025.
- DecisionPoint Financial's portfolio value rose 14% quarter-over-quarter to $392M.
Based on DecisionPoint Financial's 13F filing for Q2 2025, filed 14 Aug 2025.